Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
26 participants
INTERVENTIONAL
2021-04-08
2022-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vegan or Animal Protein Ingestion on the Recovery of Muscle Function Following Exercise
NCT04156386
Vegan Whey Protein for Muscle Anabolism and Post-exercise Recovery
NCT07119749
The Effect of Protein Ingestion on the Recovery of Skeletal Muscle Function Following Eccentric Exercise.
NCT02980900
Protein and Recovery From Exercise-induced Muscle Damage
NCT02034721
The Effects of Protein Supplementation in Females and Males Following Acute Eccentric Exercise
NCT04679519
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vegan Protein
Recover Vegan Protein Supplement
Post exercise protein supplement (26g pea protein)
Placebo
Placebo
Post exercise placebo supplement (32g maltodextrin)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Recover Vegan Protein Supplement
Post exercise protein supplement (26g pea protein)
Placebo
Post exercise placebo supplement (32g maltodextrin)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-40 years of age
Exclusion Criteria
* Inactive participants
* Habitual dietary protein intake \<0.8g/kg bw/day and \>2.0g/kg bw/day
* Regular use of nutritional supplements known to suppress inflammation or modulate protein metabolism Any diagnosed metabolic conditions (diabetes), cardiovascular disease or hypertension
* Current musculoskeletal injury
* Chronic use of anti-inflammatory medicines
* Any known disorders in muscle metabolism
* Individuals with an allergy to egg, fish, wheat or soy ingredients as the product is manufactured in a facility that contains these ingredients
* Allergy to lidocaine
* Having received or ingested a stable isotope tracer containing 15N in the past
* A personal or family history of epilepsy, seizures or schizophrenia
* Stomach bleeding or stomach ulcer
* Kidney failure
* Liver problems, such as fibrosis, cirrhosis or failure
* Crohns disease or ulcerative colitis
* Chickenpox or shingles
* Pregnant or trying to get pregnant
* Any diagnosed cardiovascular disease (e.g. deep vein thrombosis) or hypertension.
* Any diagnosed metabolic impairment (e.g. type 1 or 2 Diabetes)
* Recent (within the last 6 months) or current musculoskeletal injury (leg fracture)
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beachbody
INDUSTRY
University of Exeter
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Exeter
Exeter, Devon, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
210203-B-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.